NEW YORK, July 6 – The proposed acquisition of Aurora Biosciences by Vertex Pharmaceuticals has cleared a significant hurdle with the deal being cleared by the United States Federal Trade Commission, the companies announced Friday.

The FTC granted clearance under the Hart-Scott-Rodino Antitrust Improvements Act. The deal is still subject to approval by the companies’ shareholders at meetings scheduled for July 18.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Berkeley researchers have engineered yeast to make the molecule behind the hoppy taste of beer, Quartz reports.

King's College London researchers examine the influence of school type and genetics on academic achievement.

FiveThirtyEight writes that most who take a direct-to-consumer BRCA1/2 genetic test won't learn much from it.

In Science this week: early life experience influence somatic variation in the genome, and more.